Coverage
-
July 13, 2018
A Pennsylvania federal judge on Thursday greenlighted Ortho-Clinical Diagnostics Inc.'s $19.5 million deal to resolve allegations in multidistrict litigation that the former Johnson & Johnson unit conspired with another company to fix prices on the reagents used in blood tests.
3 other articles on this case.
View all »